Emergency Room (Children) - UMMC
Return to Locations Search
Address:
2500 N. State St.
Jackson, MS 39216
Contact Us:
(601) 984-2000
Business Hours:
Open 24 hours
Parking:
Directions:
From North State Street, turn onto campus from the stoplight at University Drive (across from Back Yard Burgers). Turn right; at the stop sign, turn left to continue on University Drive. To drop off an emergency room patient, turn left at the red "Emergency" sign.
Our Care Specialties at this location:
Our Clinical Trials offered at this location:
Researchers at UMMC are committed to discovering innovative ways to prevent and treat the diseases that affect our daily lives. Clinical research studies play a vital role in the advancement of medicine and can improve the well-being of our families, friends, communities, and future generations. In this way, participation in clinical research studies furthers our vision to create "a healthier Mississippi."
Partnering with UMMC’s researchers may have many advantages, including:
- Gaining access to investigational treatments
- Increasing knowledge about your own health
- Giving the gift of improved health to our communities and future generations
- Contributing to the advancement of science by helping researchers learn more about how the human body and mind work or by helping find a cure or better treatments for diseases
| Clinical Trials | Publish Date | Description | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
CRA-US-001: Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management (PLATINUMIRB Number: UMMC-IRB-2022-244
Published: October 11, 2022
View Locations
Clinical Trial Locations:
|
20221011160528 |
The purpose of this research is to see if a drug, called patiromer, already approved by the U.S Food and Drug Administration (FDA), can help lower potassium while patients are in the emergency department. platinum;patiromer;hyperkalemia;2022v0861 CRA-US-001 Tamara Brock unandi Emergency Medicine |
||||||||
Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of a Multi-Dose Regimen of Oral Varespladib-Methyl in Subjects Bitten by Venomous Snakes (BRAVO study – Broad-spectrum Rapid Antidote: Varespladib Oral for snakebite)IRB Number: 2021-1045
Published: January 24, 2022
View Locations
Clinical Trial Locations:
|
20220124232533 |
The purpose of this clinical research study is to learn more about the use of the study medicine, varespladib, for the treatment of snakebite. You or your child will receive a medication called Varespladib or placebo. Varespladib is an experimental treatment, meaning that it has not yet been approved by the Food and Drug Administration (FDA) for the treatment of snakebite. In this study, varespladib will be compared to a placebo. A placebo is a pill that looks exactly like the study medicine but does not contain any active ingredient, and has no therapeutic effect by itself. bravo;snakebite;varespladib-methyl (ly333013) OPX-PR-01 Simon Barinas dvearrier Emergency Medicine |